SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-16-792527
Filing Date
2016-12-14
Accepted
2016-12-14 09:35:03
Documents
10
Period of Report
2017-01-25
Effectiveness Date
2016-12-14

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d264395ddef14a.htm DEF 14A 770012
2 GRAPHIC g264395dsp3.jpg GRAPHIC 6866
3 GRAPHIC g264395dsp66a.jpg GRAPHIC 5211
4 GRAPHIC g264395dsp67.jpg GRAPHIC 3087
5 GRAPHIC g264395dsp68.jpg GRAPHIC 5235
6 GRAPHIC g264395dsp69.jpg GRAPHIC 5231
7 GRAPHIC g264395dsp70.jpg GRAPHIC 4848
8 GRAPHIC g264395dsp71.jpg GRAPHIC 5103
9 GRAPHIC g264395page34.jpg GRAPHIC 6804
10 GRAPHIC g264395page35.jpg GRAPHIC 2175
  Complete submission text file 0001193125-16-792527.txt   833819
Mailing Address 3471 RIVER HILLS DRIVE CINCINNATI OH 45244
Business Address 3471 RIVER HILLS DR CINCINNATI OH 45244 5132713700
MERIDIAN BIOSCIENCE INC (Filer) CIK: 0000794172 (see all company filings)

IRS No.: 310888197 | State of Incorp.: OH | Fiscal Year End: 0930
Type: DEF 14A | Act: 34 | File No.: 000-14902 | Film No.: 162050386
SIC: 2835 In Vitro & In Vivo Diagnostic Substances